Skip NavigationSkip to Content
Return Return to Search Results

Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors

  1. Author:
    Hill, S. A.
    Lloyd, P. A.
    McDonald, S.
    Wykoff, J.
    Derse, D.

  2. Author Address

    Natl Canc Inst, Basic Res Lab, Canc Res Ctr, Frederick, MD 21702 USA Natl Canc Inst, Basic Res Lab, Canc Res Ctr, Frederick, MD 21702 USA Natl Canc Inst, Sci Applicat Int Corp, Frederick, MD USA Derse D Natl Canc Inst, Basic Res Lab, Canc Res Ctr, Frederick, MD 21702 USA
    1. Year: 2003
  2. Journal: Journal of Infectious Diseases
    1. 188
    2. 3
    3. Pages: 424-427
  4. Type of Article: Article
  1. Abstract:

    A single-cycle infection assay with recombinant viral vectors was developed to study human T cell leukemia virus type I (HTLV-I) replication and its inhibition by antiviral agents. The susceptibility of HTLV-I to 6 nucleoside reverse- transcriptase inhibitors was examined. HTLV-I replication was inhibited by tenofovir, abacavir, lamivudine, zalcitabine, stavudine, and zidovudine.

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel